Hold Cipla, may touch Rs 750-800: Vijay Chopra

Vijay Chopra of enochventures.com told CNBC-TV18, "I think that USFDA has been brutal with the entire pharmaceutical pack. Lately, we have had news around government banning certain drugs and there is a ruling from the DPCA or drug price control about putting a cap on the prices. So this is definitely weighing heavy on all the pharma counters.""I think that Cipla is a classic case of a consumption story. The domestic formulations market is very strong and I believe that Cipla has the potential to bounce back very sharply. I see target at about Rs 750-800 if somebody holds on to it.""I think Wockhardt has slipped very fast, so one can probably switch to Wockhardt and wait for a target of Rs 1,200," he said.